These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 18772244)

  • 1. Epithelial ovarian cancer: testing the 'androgens hypothesis'.
    Olsen CM; Green AC; Nagle CM; Jordan SJ; Whiteman DC; Bain CJ; Webb PM;
    Endocr Relat Cancer; 2008 Dec; 15(4):1061-8. PubMed ID: 18772244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
    Cupisti S; Dittrich R; Binder H; Kajaia N; Hoffmann I; Maltaris T; Beckmann MW; Mueller A
    Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian morphology and prevalence of polycystic ovary syndrome in reproductive aged women with or without mild acne.
    Kelekci KH; Kelekci S; Incki K; Ozdemir O; Yilmaz B
    Int J Dermatol; 2010 Jul; 49(7):775-9. PubMed ID: 20618496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol, wine, and risk of epithelial ovarian cancer.
    Webb PM; Purdie DM; Bain CJ; Green AC
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):592-9. PubMed ID: 15066924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome.
    Pavičić Baldani D; Škrgatić L; Bukvić Mokos Z; Trgovčić I
    Acta Dermatovenerol Croat; 2013; 21(2):105-12. PubMed ID: 24001418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum?
    Jordan SJ; Green AC; Whiteman DC; Webb PM;
    Gynecol Oncol; 2007 Nov; 107(2):223-30. PubMed ID: 17662378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometriosis and its treatment with danazol or lupron in relation to ovarian cancer.
    Cottreau CM; Ness RB; Modugno F; Allen GO; Goodman MT
    Clin Cancer Res; 2003 Nov; 9(14):5142-4. PubMed ID: 14613992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body size and risk of epithelial ovarian and related cancers: a population-based case-control study.
    Olsen CM; Nagle CM; Whiteman DC; Purdie DM; Green AC; Webb PM
    Int J Cancer; 2008 Jul; 123(2):450-456. PubMed ID: 18449887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of cutaneous manifestations of hyperandrogenism in obese and non-obese Taiwanese women.
    Yang JH; Weng SL; Lee CY; Chou SY; Hsu CS; Hsu MI
    Arch Gynecol Obstet; 2010 Sep; 282(3):327-33. PubMed ID: 20431891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.
    Riman T; Nilsson S; Persson IR
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):783-95. PubMed ID: 15315588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acne, hirsutism, and alopecia in adolescent girls. Clinical expressions of androgen excess.
    Rosenfield RL; Lucky AW
    Endocrinol Metab Clin North Am; 1993 Sep; 22(3):507-32. PubMed ID: 8243445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychotropic medication use and risk of epithelial ovarian cancer.
    Harlow BL; Cramer DW; Baron JA; Titus-Ernstoff L; Greenberg ER
    Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):697-702. PubMed ID: 9718222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body size and risk of epithelial ovarian cancer (United States).
    Rossing MA; Tang MT; Flagg EW; Weiss LK; Wicklund KG; Weiss NS
    Cancer Causes Control; 2006 Jun; 17(5):713-20. PubMed ID: 16633919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated rates of testosterone-related disorders in women with autism spectrum conditions.
    Ingudomnukul E; Baron-Cohen S; Wheelwright S; Knickmeyer R
    Horm Behav; 2007 May; 51(5):597-604. PubMed ID: 17462645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgens and women's health.
    Redmond GP
    Int J Fertil Womens Med; 1998; 43(2):91-7. PubMed ID: 9609208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovary syndrome in bulimic women--an evaluation based on the new diagnostic criteria.
    Naessén S; Carlström K; Garoff L; Glant R; Hirschberg AL
    Gynecol Endocrinol; 2006 Jul; 22(7):388-94. PubMed ID: 16864149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual case of oral hirsutism in a patient with polycystic ovarian syndrome.
    Femiano F; Rullo R; Serpico R; Lanza A; Festa VM; Laino G
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Dec; 108(6):e13-6. PubMed ID: 19913714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Height, age at menarche, and risk of epithelial ovarian cancer.
    Jordan SJ; Webb PM; Green AC
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):2045-8. PubMed ID: 16103459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for benign serous and mucinous epithelial ovarian tumors.
    Jordan SJ; Green AC; Whiteman DC; Webb PM
    Obstet Gynecol; 2007 Mar; 109(3):647-54. PubMed ID: 17329516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgenic progestins in oral contraceptives and the risk of epithelial ovarian cancer.
    Greer JB; Modugno F; Allen GO; Ness RB
    Obstet Gynecol; 2005 Apr; 105(4):731-40. PubMed ID: 15802398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.